Primary Care Clinics in Blakely, GA Accepting Medicare
7 Primary Care Clinics found. Showing 1 - 7
 Pioneer Family Care Clinic/Center Medicare: Not Enrolled in Medicare Practice Location: 11168 Columbia St, Blakely, GA 39823 Phone: 229-723-4313 |
Pioneer Health Services Of Early County, Llc Clinic/Center Medicare: Not Enrolled in Medicare Practice Location: 11168 Columbia St, Suite B, Blakely, GA 39823 Phone: 229-723-8300 |
Blakely Medical Group Clinic/Center - Rural Health Medicare: Not Enrolled in Medicare Practice Location: 11168 Columbia St, Suite B, Blakely, GA 39823 Phone: 229-723-4313 Fax: 229-723-3734 |
Pioneer Family Medical Of Early Clinic/Center - Rural Health Medicare: Not Enrolled in Medicare Practice Location: 11045 Columbia St, Suite B, Blakely, GA 39823 Phone: 229-723-4313 Fax: 229-723-3734 |
Primary Care Of Southwest Georgia, Inc. Family Medicine Medicare: Medicare Enrolled Practice Location: 360 College Street, Blakely, GA 39823 Phone: 229-723-2660 Fax: 229-723-2663 |
Lifebrite Family Medical Of Early Clinic/Center - Rural Health Medicare: Medicare Enrolled Practice Location: 11045 Columbia St, Suite B, Blakely, GA 39823 Phone: 229-723-4313 |
Primary Care Of Southwest Georgia, Inc Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Medicare Enrolled Practice Location: 283 Martin Luther King Jr Blvd, Blakely, GA 39823 Phone: 229-723-4101 |
News Archive
Sleep does not improve memory in eyewitness identifications
A new study from British researchers has revealed that sleep does not improve memory in an eyewitness. The study titled, "The impact of sleep on eyewitness identifications," was published in the latest issue of the journal Royal Society Open Science on the 4th of December 2019.
Mirna enrolls first patient in hematological malignancy cohort of MRX34 Phase 1 clinical trial
Mirna Therapeutics, Inc., a clinical-stage biopharmaceutical company pioneering microRNA-based Replacement Therapy to treat cancer, today announced the enrollment of the first patient in the hematological malignancy cohort of its ongoing Phase 1 clinical trial of MRX34, the company's lead product candidate and first microRNA mimic in human clinical trials in oncology.
Study identifies patterns of chronic lymphocytic leukemia growth
In patients with chronic lymphocytic leukemia, the rate of disease growth is apt to follow one of three trajectories: relentlessly upward, steadily level, or something in between, scientists at Dana-Farber Cancer Institute, the Broad Institute of MIT and Harvard, Massachusetts General Hospital, and the University of Washington report in a new study.
Shire files lawsuit against Watson over ADDERALL XR patent infringement
Shire plc, announces that its subsidiary Shire LLC has filed a lawsuit in the U.S. District Court for the Southern District of New York against Watson Pharmaceuticals, Inc. and its subsidiaries Watson Laboratories, Inc.-Florida, Watson Pharma, Inc., Andrx Corporation, and Andrx Pharmaceuticals, L.L.C. for infringement of Shire's U.S. Reissue Patent No. RE 41,148, U.S. Reissue Patent No. RE 42,096 and U.S. Patent No. 6,913,768 and also for breach of contract.
Australian cricketers have had their muscles scanned by researchers to prevent muscle deterioration and injury
The 24-man-squad from Cricket Australia's Centre of Excellence in Brisbane, were examined by University of Queensland's senior physiotherapy lecturer Dr Julie Hides.
› Verified 2 days ago